The Prevalence of Healthcare-associated Infection in Medical Intensive Care Units in Tunisia

We aimed to determine the prevalence of HAI in medical Tunisian ICUs. Secondary endpoints were to identify the predominant infecting microorganisms and evaluate independent risk factors of HAIs.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cross Infection Critical Care Disease Attributes Epidemiology Iatrogenic Disease Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Prevalence

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical ICU

Tunis, Ariana Governorate, 2080, Tunisia

About this study

In Tunisia, there is no national or regional monitoring system of HAI. It is worth noting that HCAIs in intensive care unit (ICU) are more common and life threatening than in general ward because of the frequent use of invasive procedures and multiple therapies.

Controlling this fatal scourge should begin with greater awareness of HAI frequency and ICU ecology. That is why conducting multi-center Tunisian studies is necessary to guide control measurements against HAI and to improve surveillance and infection-control practices. NOSOREA1 study (Tunis Med. 2018 Oct-Nov;96(10-11):731-736) was conducted in 2017 and showed that HAI prevalence within Tunisian ICUs was 25.2% CI 95% [15-35]. Five years later, it is high time to update our finding.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients occupying an ICU bed over a 48-hour period
Age >=18 years

Exclusion criteria

no criteria

Treatment and study plan

Primary outcomes

Determine the prevalence of healthcare-associated infection in medical Tunisian ICUs

Time frame: September 27th, 2022

The number of infected patients divided by the total number of patients at the day of the study

Secondary outcomes

Identify independent risk factors of HAIs.

Time frame: September 27th, 2022

Multivariate logistic regression model

Sponsors and collaborators

Lead sponsor

Abderrahmane Mami Hospital

Other

Registry information

Official study title

The Prevalence of Healthcare-associated Infection in Medical Intensive Care Units in Tunisia: NOSOREA2 Study

Acronym: NOSOREA2

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Sep 21, 2022
Registry last updated: Aug 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed